Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Kobayashi factory searched over deaths possibly linked to supplements

Published 03/30/2024, 12:31 PM
Updated 03/30/2024, 12:36 PM
© Reuters. Japanese health ministry officials head to search a Kobayashi Pharmaceutical Co. factory in Osaka, Japan March 30, 2024, in this photo taken by Kyodo. Mandatory credit Kyodo/via REUTERS

TOKYO (Reuters) -Japanese health officials searched a Kobayashi Pharmaceutical factory on Saturday after the drugmaker reported five deaths possibly linked to dietary supplements using red yeast rice, an official said.

The Ministry of Health, Labour and Welfare and the City of Osaka jointly inspected the factory in Osaka that had made the supplements containing "Beni-Koji" red yeast, suspected of having caused health damage, the ministry official said.

News footage showed officials entering the factory, and the official said the ministry could search other related locations. The factory, which made the product until December, had been closed due to ageing facilities, Japanese media said.

The Osaka-based company could not immediately be reached for comment. Yuko Tomiyama, head of Kobayashi's investor relations, told public broadcaster NHK the firm intends to sincerely deal with the matter and fully cooperate with the investigation.

Kobayashi said on Friday it was investigating a suspected link between the products and their effects on the kidney since it received reports of kidney disease linked to the products.

As of Thursday evening, 114 people had been hospitalised and five had died after taking the supplements, which were marketed as helping lower cholesterol levels, according to the company.

Kobayashi said it is examining the earnings impact of the latest issues.

Japanese Chief Cabinet Secretary Yoshimasa Hayashi criticised the company on Tuesday for its slow response, saying it was regrettable that Kobayashi took two months to announce the health impacts of its products.

The company has been recalling products with Beni-Koji in recent days after receiving reports of kidney ailments. Its products are also consumed in places such as China, and Japanese media said a case of acute renal failure had been reported in Taiwan.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

A Chinese consumers association urged consumers to stop using affected products, saying it was concerned about the risk of Kobayashi products, state media reported on Friday.

Beni-Koji contains Monascus purpureus, a red mould that is also used as a red colouring in some foods.

Puberulic acid - a potent antibacterial and antimalarial agent that can be produced from blue mould and can be toxic - was confirmed in a batch of the products that caused health complaints, Japanese media said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.